Danaher Corp.

NYSE:DHR  
313.48
+2.74 (+0.88%)
4:00:00 PM EDT: $313.40 -0.08 (-0.03%)
Products

Beckman Coulter's Sars-Cov-2 IgG II Antibody Test Receives Emergency Use Authorization From FDA

Published: 03/23/2021 18:01 GMT
Danaher Corp. (DHR) - Beckman Coulter's Sars-cov-2 Igg Ii Antibody Test Receives Emergency Use Authorization From the FDA.
Beckman Coulter - Assay Available to Ship in U.S. and Countries Accepting Ce Mark.